1109 related articles for article (PubMed ID: 34254524)
1. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
[TBL] [Abstract][Full Text] [Related]
2. A Platform for Comprehensive Genomic Profiling in Human Cancers and Pharmacogenomics Therapy Selection.
Kou T; Kanai M; Kamada M; Nakatsui M; Matsumoto S; Okuno Y; Muto M
Methods Mol Biol; 2018; 1825():413-424. PubMed ID: 30334215
[TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors.
Wakai T; Prasoon P; Hirose Y; Shimada Y; Ichikawa H; Nagahashi M
Int J Clin Oncol; 2019 Feb; 24(2):115-122. PubMed ID: 30515675
[TBL] [Abstract][Full Text] [Related]
4. Genomic profiling in oncology clinical practice.
Rodríguez N; Viñal D; Rodríguez-Cobos J; De Castro J; Domínguez G
Clin Transl Oncol; 2020 Sep; 22(9):1430-1439. PubMed ID: 31981077
[TBL] [Abstract][Full Text] [Related]
5. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
Syn NL; Yong WP; Goh BC; Lee SC
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
[TBL] [Abstract][Full Text] [Related]
6. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy.
von Baumgarten L; Kumbrink J; Jung A; Reischer A; Flach M; Liebmann S; Metzeler KH; Holch JW; Niyazi M; Thon N; Straube A; von Bergwelt-Baildon M; Heinemann V; Kirchner T; Westphalen CB
Theranostics; 2020; 10(2):856-866. PubMed ID: 31903155
[No Abstract] [Full Text] [Related]
8. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive molecular profiling broadens treatment options for breast cancer patients.
Kawaji H; Kubo M; Yamashita N; Yamamoto H; Kai M; Kajihara A; Yamada M; Kurata K; Kaneshiro K; Harada Y; Hayashi S; Shimazaki A; Mori H; Akiyoshi S; Oki E; Oda Y; Baba E; Mori M; Nakamura M
Cancer Med; 2021 Jan; 10(2):529-539. PubMed ID: 33274848
[TBL] [Abstract][Full Text] [Related]
10. Precision Oncology: Who, How, What, When, and When Not?
Schwartzberg L; Kim ES; Liu D; Schrag D
Am Soc Clin Oncol Educ Book; 2017; 37():160-169. PubMed ID: 28561651
[TBL] [Abstract][Full Text] [Related]
11. The possibility of clinical sequencing in the management of cancer.
Kou T; Kanai M; Matsumoto S; Okuno Y; Muto M
Jpn J Clin Oncol; 2016 May; 46(5):399-406. PubMed ID: 26917600
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive genomic profiling for oncological advancements by precision medicine.
Pankiw M; Brezden-Masley C; Charames GS
Med Oncol; 2023 Nov; 41(1):1. PubMed ID: 37993657
[TBL] [Abstract][Full Text] [Related]
13. Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
Stockley TL; Oza AM; Berman HK; Leighl NB; Knox JJ; Shepherd FA; Chen EX; Krzyzanowska MK; Dhani N; Joshua AM; Tsao MS; Serra S; Clarke B; Roehrl MH; Zhang T; Sukhai MA; Califaretti N; Trinkaus M; Shaw P; van der Kwast T; Wang L; Virtanen C; Kim RH; Razak AR; Hansen AR; Yu C; Pugh TJ; Kamel-Reid S; Siu LL; Bedard PL
Genome Med; 2016 Oct; 8(1):109. PubMed ID: 27782854
[TBL] [Abstract][Full Text] [Related]
14. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
15. Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to Therapy.
Sabari JK; Santini F; Bergagnini I; Lai WV; Arbour KC; Drilon A
Curr Oncol Rep; 2017 Apr; 19(4):24. PubMed ID: 28303491
[TBL] [Abstract][Full Text] [Related]
16. The emerging roles of NGS in clinical oncology and personalized medicine.
Hussen BM; Abdullah ST; Salihi A; Sabir DK; Sidiq KR; Rasul MF; Hidayat HJ; Ghafouri-Fard S; Taheri M; Jamali E
Pathol Res Pract; 2022 Feb; 230():153760. PubMed ID: 35033746
[TBL] [Abstract][Full Text] [Related]
17. Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience.
Lih CJ; Takebe N
Curr Probl Cancer; 2017; 41(3):201-211. PubMed ID: 28625332
[TBL] [Abstract][Full Text] [Related]
18. Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: Practical indications from an Italian multidisciplinary group.
Malapelle U; Donne AD; Pagni F; Fraggetta F; Rocco EG; Pasello G; Perrone G; Pepe F; Vatrano S; Pignata S; Pinto C; Pruneri G; Russo A; Soto Parra HJ; Vallone S; Marchetti A; Troncone G; Novello S
Crit Rev Oncol Hematol; 2024 Jan; 193():104217. PubMed ID: 38040072
[TBL] [Abstract][Full Text] [Related]
19. Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology.
Patel SP; Schwaederle M; Daniels GA; Fanta PT; Schwab RB; Shimabukuro KA; Kesari S; Piccioni DE; Bazhenova LA; Helsten TL; Lippman SM; Parker BA; Kurzrock R
Oncotarget; 2015 Oct; 6(32):32602-9. PubMed ID: 26418953
[TBL] [Abstract][Full Text] [Related]
20. Pediatric oncology enters an era of precision medicine.
Seibel NL; Janeway K; Allen CE; Chi SN; Cho YJ; Glade Bender JL; Kim A; Laetsch TW; Irwin MS; Takebe N; Tricoli JV; Parsons DW
Curr Probl Cancer; 2017; 41(3):194-200. PubMed ID: 28343740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]